Frequently Asked Questions
The market is segmented based on Global Enzyme Immunoassay (EIA) Reagents and Devices Market, By Technology (Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence, Immunoassays, Radioimmunoassay and Others), Product Type (Analysers and Reagents), Application (Oncology, Infectious diseases, Cardiology, Bone and Mineral, Endocrinology, Autoimmunity, Toxicology, Haematology, Neonatal Screening, and Others), End Users (Hospitals, Laboratories, Academics, Pharmaceutical Industries and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
.
The Global Enzyme Immunoassay Eia Reagents And Devices Market size was valued at USD 0.00 USD Billion in 2021.
The Global Enzyme Immunoassay Eia Reagents And Devices Market is projected to grow at a CAGR of 3.63% during the forecast period of 2022 to 2028.
The major players operating in the market include Thermo Fisher Scientific , BD, QIAGEN, Agilent Technologies , Bio-Rad Laboratories , F. Hoffmann-La Roche Ltd, Hologic , Abbott, DSM, DuPont, bioMerieux SA, Promega Corporation, Siemens Healthcare Private Limited, Danaher, Sartorius AG, Sysmex Corporation, Phoenix Pharmaceuticals, DiaSorin S.p.A., Merck KGaA
-.
